Equine Strangles: Streptococcus equi subsp. equi Diagnostic Testing and Outbreak Management

Introduction

Equine strangles is a highly contagious upper respiratory tract infection of equids caused by the Lancefield group C beta-hemolytic bacterium Streptococcus equi subsp. equi (S. equi). The disease is characterized by acute pyrexia, mucopurulent nasal discharge, and suppurative lymphadenopathy of the submandibular and retropharyngeal lymph nodes, which frequently abscess and rupture [1, 2]. Morbidity rates in naive populations can exceed 90%, while mortality is generally low (1% to 5%) and typically results from metastatic abscessation (bastard strangles) or purpura hemorrhagica, an immune-mediated vasculitis [3, 4]. The economic impact of strangles on the equine industry is substantial, encompassing veterinary costs, lost training days, movement restrictions, and prolonged quarantine periods [5].

The causative agent, S. equi, is a host-adapted clone of the commensal Streptococcus equi subsp. zooepidemicus (S. zooepidemicus). Comparative genomic analyses have demonstrated that S. equi evolved from an ancestral S. zooepidemicus strain through gene acquisition and loss events, including the acquisition of prophage-encoded superantigens (SePE-H, SePE-I, SePE-L, SePE-M) and the pyrogenic mitogen SeM, which are central to its virulence [6, 7]. The bacterium is an obligate equine pathogen with no known environmental reservoir, though it can survive in water and on fomites for several days under appropriate conditions [8].

Effective control of strangles hinges on rapid and accurate diagnostic testing to identify active infections and, critically, to detect asymptomatic carriers that harbor S. equi in the guttural pouches. These carriers are the primary mechanism for disease persistence and reintroduction into naive populations [9, 10]. This article provides a detailed technical review of the diagnostic modalities available for S. equi detection, including bacterial culture, polymerase chain reaction (PCR), and serological assays targeting the M-protein SeM. It further outlines evidence-based outbreak management protocols, biosecurity measures, and strategies for clearing guttural pouch carriers.

Pathogenesis and Clinical Presentation

Mechanism of Infection and Host Interaction

S. equi is transmitted via direct contact with infected horses, indirect contact through contaminated fomites (water buckets, feed tubs, grooming equipment, human hands), or inhalation of aerosolized droplets [11]. The bacterium adheres to the epithelium of the nasopharynx and tonsillar tissues via surface fibrillae and hyaluronic acid capsule, which inhibits phagocytosis [12]. The hyaluronic acid capsule is structurally identical to host hyaluronan, providing a mechanism of molecular mimicry that impedes opsonization [13].

Following adherence, S. equi invades the palatine and pharyngeal tonsils and is transported to the regional lymph nodes (submandibular and retropharyngeal) via afferent lymphatics [14]. Within the lymph node, the bacterium resists killing by neutrophils and macrophages, in part due to the antiphagocytic M-protein SeM and the complement-inhibitory protein Se18.9 [15, 16]. The resultant suppurative inflammation leads to abscess formation, with neutrophil infiltration and liquefactive necrosis. Abscesses typically mature over 7 to 14 days post-infection, at which point they may rupture externally through the skin or internally into the guttural pouches or pharynx [17].

Clinical Forms

The classic presentation includes a sudden onset of pyrexia (39.5 to 41.0 degrees Celsius), depression, anorexia, and a serous to mucopurulent bilateral nasal discharge. Palpation of the intermandibular space reveals painful, edematous swelling that progresses to palpable abscessation [1, 2]. Complications include:

1. Bastard strangles: Metastatic abscessation in internal organs (lungs, liver, spleen, brain) resulting from hematogenous or lymphatic dissemination [3].
2. Purpura hemorrhagica: An immune-complex mediated vasculitis characterized by well-demarcated subcutaneous edema, petechial hemorrhages on mucous membranes, and urticaria. This condition is associated with high titers of antibodies against the M-protein SeM [4, 18].
3. Guttural pouch empyema and chondroids: Accumulation of purulent exudate within the guttural pouches, which may inspissate to form solid concretions (chondroids). This condition is the hallmark of the asymptomatic carrier state [9, 19].
4. Laryngeal hemiplegia and dysphagia: Secondary to compression of the recurrent laryngeal nerve or pharyngeal structures by enlarged retropharyngeal lymph nodes [20].

Diagnostic Testing

Sample Collection and Handling

The choice of diagnostic specimen depends on the clinical stage of disease and the purpose of testing (confirmation of active infection versus carrier detection). For horses with acute clinical signs, samples should be collected from the following sites:

• Nasal swabs: Deep nasopharyngeal swabs (sterile, flocked swabs) inserted to the level of the medial canthus of the eye are preferred over superficial nasal swabs, as they sample the tonsillar and nasopharyngeal epithelium where S. equi colonizes [21].
• Abscess exudate: Aspirated pus from unruptured abscesses or swabs of draining tracts. This material has the highest bacterial load and is the specimen of choice for culture [22].
• Guttural pouch lavage: For carrier detection, a transendoscopic guttural pouch lavage is performed using 60 mL of sterile saline. The lavage fluid is collected for PCR and culture. Alternatively, a guarded uterine swab passed through the biopsy channel of the endoscope can be used to sample the pouch lining directly [9, 23].

Samples should be placed in transport medium (e.g., Amies with charcoal) and refrigerated at 4 degrees Celsius if processing is delayed beyond 2 hours. For PCR, dry swabs can be stored at 4 degrees Celsius for up to 72 hours or frozen at -20 degrees Celsius for longer storage [24].

Bacterial Culture

Bacterial culture remains a cornerstone of strangles diagnosis, particularly for antimicrobial susceptibility testing and epidemiological typing. S. equi is a fastidious, beta-hemolytic, gram-positive coccus that forms chains. It grows on 5% sheep blood agar as small, mucoid, or matt colonies surrounded by a wide zone of beta-hemolysis [25].

Culture protocol:

1. Inoculation: Swabs are streaked onto Columbia blood agar and incubated at 37 degrees Celsius in 5% CO2 for 24 to 48 hours.
2. Identification: Presumptive identification is based on colony morphology, Gram stain, catalase negativity, and Lancefield group C carbohydrate antigen detection using latex agglutination [26].
3. Biochemical confirmation: S. equi ferments trehalose and sorbitol, a key differential feature from S. zooepidemicus, which ferments sorbitol but not trehalose. Commercial biochemical panels (e.g., API 20 Strep) can provide definitive identification [27].
4. Sensitivity: Culture sensitivity is highly dependent on sample quality and bacterial load. In acute cases with abscess exudate, sensitivity approaches 95%. However, in carrier horses with low bacterial shedding, sensitivity drops to 30% to 50% compared to PCR [28, 29].

Limitations: Culture requires viable organisms, is subject to overgrowth by commensal flora, and has a turnaround time of 48 to 72 hours. False negatives are common in samples from horses that have received antimicrobial therapy within the preceding 7 to 14 days [30].

Polymerase Chain Reaction (PCR)

PCR has become the diagnostic test of choice for S. equi detection due to its high sensitivity, rapid turnaround time (2 to 4 hours), and ability to detect non-viable organisms. Real-time PCR (qPCR) assays targeting the SeM gene (encoding the M-protein) or the superantigen genes (SePE-I, SePE-H) are widely used [31, 32].

Assay characteristics:

• Target gene: The SeM gene is present in all virulent strains of S. equi and is absent in the closely related S. zooepidemicus, providing excellent specificity [33].
• Analytical sensitivity: qPCR can detect as few as 10 to 100 colony-forming units (CFU) per reaction, corresponding to a limit of detection of approximately 10^3 CFU/mL in clinical samples [34].
• Diagnostic sensitivity and specificity: In a study comparing qPCR to culture on 1,200 clinical samples, qPCR demonstrated a sensitivity of 97.3% and a specificity of 99.1% [35]. For guttural pouch lavage samples from carrier horses, qPCR sensitivity was 92% compared to 48% for culture [29].

Multiplex PCR: Some laboratories employ multiplex assays that simultaneously detect S. equi and S. zooepidemicus, allowing differentiation of the two subspecies in mixed infections [36].

Interpretation considerations:

• A positive PCR result in a horse with clinical signs confirms active infection.
• A positive PCR result in a clinically normal horse may indicate an active carrier, a recent resolved infection with residual DNA, or contamination. Repeat testing after 7 to 14 days is recommended to confirm carrier status [37].
• A negative PCR result from a single nasopharyngeal swab does not rule out infection, particularly in early disease (first 24 hours) or in horses with low-level shedding. Pooled testing of multiple swabs (nasal, guttural pouch) increases sensitivity [38].

Serological Testing: M-Protein Antibody Detection

Serological assays measure antibodies against the M-protein SeM, which is a protective antigen and a key virulence factor. The most common format is an indirect enzyme-linked immunosorbent assay (ELISA) using recombinant SeM as the coating antigen [39]. This assay is analogous in principle to the Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus but uses a bacterial antigen target.

Interpretation of SeM ELISA results:

Clinical utility:

1. Herd screening: Serology is used to identify horses that have been exposed to S. equi, even in the absence of clinical signs. This is critical for pre-purchase examinations and for screening horses prior to introduction to a naive population [40].
2. Carrier detection: A persistently high SeM titer ( > 1:1,600) in a clinically normal horse is strongly predictive of guttural pouch carriage. In one study, 85% of horses with titers > 1:1,600 were confirmed as carriers by PCR and endoscopy [41].
3. Vaccine response monitoring: SeM ELISA can differentiate vaccinated horses from naturally infected horses, as vaccines typically induce lower and shorter-lived antibody responses [42].

Limitations: Serology cannot distinguish between active infection and resolved infection. A single positive titer indicates exposure but not necessarily current shedding. Paired serology (acute and convalescent samples taken 14 to 21 days apart) is required to confirm active infection [43].

Comparison of Diagnostic Modalities

Guttural Pouch Carriers: The Reservoir of Infection

The guttural pouches are paired, air-filled diverticula of the auditory tubes that are unique to equids. They are lined by respiratory epithelium and communicate with the nasopharynx via the pharyngeal openings of the auditory tubes. In horses that have recovered from strangles, S. equi can persist within the guttural pouches for months to years, forming biofilms on the mucosal surface or within inspissated pus (chondroids) [9, 44].

Mechanism of persistence: S. equi evades host immunity within the guttural pouch by downregulating expression of surface antigens, including SeM, and by forming a polysaccharide-rich biofilm that protects against phagocytosis and antimicrobial penetration [45]. The biofilm matrix is composed of extracellular DNA, proteins, and hyaluronic acid [46].

Detection of carriers: The gold standard for carrier detection is transendoscopic visualization of the guttural pouches combined with PCR testing of lavage fluid. Endoscopic findings may include:

• Mucopurulent exudate (empyema)
• Chondroids (solid, yellow-white concretions)
• Mucosal hyperplasia or ulceration
• Normal-appearing mucosa with positive PCR (occult carriers) [19, 23]

Prevalence: Estimates suggest that 5% to 10% of horses that recover from strangles become long-term carriers. The carrier state is more common in horses that had severe or complicated infections, particularly those with retropharyngeal abscessation that ruptured into the guttural pouch [10, 47].

Outbreak Management

Initial Response and Containment

When a case of strangles is suspected or confirmed, the following steps should be implemented immediately:

1. Isolation: The affected horse(s) should be moved to a dedicated isolation facility that is physically separate from the main stable. Isolation should be maintained for a minimum of 4 weeks after clinical signs resolve [48].
2. Movement restriction: No horses should enter or leave the premises. All equine activities (competitions, training, breeding) should be suspended until the outbreak is declared resolved [49].
3. Cohorting: Horses on the premises should be divided into three groups based on risk:
   • Group A (Confirmed cases): Horses with positive PCR or culture results.
   • Group B (Exposed, clinically normal): Horses that have had direct or indirect contact with Group A.
   • Group C (Unexposed): Horses with no known contact and negative PCR results. Each group should be housed in separate barns or paddocks with dedicated equipment and personnel [50].

Diagnostic Testing During an Outbreak

A systematic testing protocol is essential for outbreak control. The following algorithm is recommended:

graph TD
    A[Clinical Case Suspected], > B{Nasopharyngeal Swab + Abscess Pus}
    B, > C[PCR for SeM]
    C, > D{Result}
    D, >|Positive| E[Confirm Active Infection]
    D, >|Negative| F[Repeat PCR in 48h; Consider Culture]
    E, > G[Isolate Horse; Treat Supportively]
    G, > H[Clinical Recovery]
    H, > I[Guttural Pouch Endoscopy + Lavage PCR at Week 4]
    I, > J{Carrier?}
    J, >|Yes| K[Treat with Lavage +/- Topical Antimicrobials]
    J, >|No| L[Release from Isolation after 3 Negative PCRs]
    K, > M[Repeat PCR at Week 8]
    M, > N{Cleared?}
    N, >|Yes| L
    N, >|No| O[Consider Surgical Intervention]
    
    P[Exposed Horses], > Q[PCR on Day 0, Day 7, Day 14]
    Q, > R{Any Positive?}
    R, >|Yes| E
    R, >|No| S[Monitor for Pyrexia; Repeat PCR if Febrile]

Biosecurity Protocols

Physical barriers and zoning:

• Establish a clearly demarcated isolation zone with a separate entrance and exit.
• Use footbaths containing 2% chlorhexidine or 1% Virkon at the entrance to each zone. Change footbaths daily [48].
• Dedicate separate grooming equipment, halters, lead ropes, water buckets, and feed tubs to each zone. Disinfect all equipment with 1% sodium hypochlorite or 2% accelerated hydrogen peroxide between uses [8].

Personnel protocols:

• Assign dedicated staff to each zone. Staff should not move from high-risk (Group A) to low-risk (Group C) areas on the same day.
• Wear disposable gloves, coveralls, and boots when handling infected horses. Dispose of gloves and coveralls after each use [49].
• Shower or change clothing and footwear before leaving the isolation area.

Environmental decontamination:

• S. equi is susceptible to most common disinfectants, including quaternary ammonium compounds, chlorhexidine, and bleach. However, it can survive in organic matter (manure, bedding) for up to 7 days [8].
• Remove all organic material (bedding, manure) from stalls before applying disinfectant. Allow a contact time of at least 10 minutes.
• Water troughs and buckets should be emptied, scrubbed with detergent, disinfected, and rinsed daily [50].

Treatment of Carriers

Medical management:

• Guttural pouch lavage: Performed via transendoscopic catheterization. The pouch is flushed with 500 mL to 1 L of sterile saline or a dilute antiseptic solution (0.1% povidone-iodine) daily for 5 to 7 days [19].
• Topical antimicrobials: After lavage, instillation of 20 mL of a 1% ceftiofur solution or 10 mL of 2.5% gentamicin solution into the guttural pouch has been described [23].
• Systemic antimicrobials: The use of systemic antimicrobials for carrier clearance is controversial. While penicillin G (22,000 IU/kg IM BID) or ceftiofur (2.2 mg/kg IV BID) can eliminate S. equi from the guttural pouch, they may also suppress the immune response and increase the risk of re-infection [30].

Surgical intervention:

• For horses with chondroids that do not resolve with lavage, surgical removal via a modified Whitehouse approach (viborg's triangle) or transendoscopic laser fragmentation is indicated [19].

Clearance confirmation:

• A horse is considered cleared of the carrier state after three consecutive negative PCR results from guttural pouch lavage samples collected at weekly intervals [37].

Vaccination and Immunity

Two types of vaccines are available: an intramuscular killed whole-cell bacterin and an intranasal modified-live vaccine (MLV). The MLV vaccine induces mucosal IgA and systemic IgG responses and provides superior protection against challenge compared to the bacterin [42]. However, the MLV can cause adverse reactions, including abscess formation at the injection site and, rarely, purpura hemorrhagica. Vaccination does not prevent infection but reduces the severity of clinical signs and the duration of shedding [51].

Serological monitoring post-vaccination: SeM ELISA titers following vaccination are typically low (1:200 to 1:800) and decline within 3 to 6 months. A titer > 1:1,600 in a vaccinated horse suggests natural infection or carrier status [41].

Conclusion

Equine strangles remains a significant challenge for the equine industry due to its high morbidity, the existence of asymptomatic carriers, and the limitations of current vaccines. The diagnostic armamentarium has advanced considerably with the adoption of SeM-targeted qPCR, which offers superior sensitivity for both acute case confirmation and carrier detection. Serological testing via SeM ELISA provides complementary information for herd screening and risk assessment. Effective outbreak management requires a multi-pronged approach: rapid diagnostic testing, strict biosecurity protocols, cohorting of horses, and systematic clearance of guttural pouch carriers. The integration of molecular diagnostics with evidence-based biosecurity remains the most effective strategy for controlling this economically important pathogen.

References

[1] Sweeney CR, Timoney JF, Newton JR, Hines MT. Streptococcus equi infections in horses: guidelines for treatment, control, and prevention of strangles. Journal of Veterinary Internal Medicine. 2005;19(1):123-134.

[2] Boyle AG, Timoney JF, Newton JR, Hines MT, Waller AS, Buchanan BR. Streptococcus equi infections in horses: guidelines for treatment, control, and prevention of strangles. Journal of Veterinary Internal Medicine. 2018;32(2):633-647.

[3] Pusterla N, Watson JL, Affolter VK, Magdesian KG, Wilson WD, Carlson GP. Purpura hemorrhagica in 53 horses. Veterinary Record. 2003;153(4):118-121.

[4] Galan JE, Timoney JF. Immune complexes in purpura hemorrhagica of the horse contain IgA and M antigen of Streptococcus equi. Journal of Immunology. 1985;135(5):3134-3139.

[5] Ivens PA, Matthews D, Webb K, Newton JR, Steward K, Waller AS, et al. Molecular characterisation of 'strangles' outbreaks in the UK: the use of M-protein typing for epidemiological surveillance. Equine Veterinary Journal. 2011;43(3):359-364.

[6] Holden MT, Heather Z, Paillot R, Steward KF, Webb K, Ainslie F, et al. Genomic evidence for the evolution of Streptococcus equi: host restriction, increased virulence, and genetic exchange with human pathogens. PLoS Pathogens. 2009;5(3):e1000346.

[7] Paillot R, Robinson C, Steward K, Wright N, Jourdan T, Butcher N, et al. Contribution of each of four superantigens to Streptococcus equi-induced mitogenicity, gamma interferon synthesis, and immunity. Infection and Immunity. 2010;78(4):1728-1739.

[8] Weese JS, Jarlot C, Joly B, Lefebvre SL, Morley PS, Prescott JF, et al. Survival of Streptococcus equi on surfaces and in water. Veterinary Record. 2009;165(21):629-630.

[9] Newton JR, Wood JL, Dunn KA, DeBrauwere MN, Chanter N. Naturally occurring persistent and asymptomatic infection of the guttural pouches of horses with Streptococcus equi. Veterinary Record. 1997;140(4):84-90.

[10] Wood JL, Chanter N, Newton JR, Burrell MH, Dugdale D, Windsor HM, et al. An outbreak of strangles in a group of riding horses: a clinical, bacteriological, and serological study. Equine Veterinary Journal. 1993;25(6):496-501.

[11] Timoney JF. The pathogenic equine streptococci. Veterinary Research. 2004;35(4):397-409.

[12] Chanter N, Collin NC, Mumford JA. Resistance of Streptococcus equi to phagocytosis. Research in Veterinary Science. 1994;56(1):92-98.

[13] Wessels MR, Moses AE, Goldberg JB, DiCesare TJ. Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. Proceedings of the National Academy of Sciences. 1991;88(19):8317-8321.

[14] Timoney JF, Kumar P. Early pathogenesis of equine Streptococcus equi infection (strangles). Equine Veterinary Journal. 2008;40(7):637-642.

[15] Timoney JF, Artiushin SC, Boschwitz JS. Comparison of the sequences and functions of Streptococcus equi M-like proteins SeM and SzPSe. Infection and Immunity. 1997;65(9):3600-3605.

[16] Tiwari R, Artiushin SC, Timoney JF. Se18.9, an antiphagocytic factor of Streptococcus equi. Veterinary Microbiology. 2007;121(1-2):105-115.

[17] Ford J, Lokai MD. Complications of Streptococcus equi infection. Equine Veterinary Education. 2000;12(5):267-272.

[18] Heath SE, Geor RJ, Tabel H, McGuirk SM. Purpura hemorrhagica in a horse. Journal of the American Veterinary Medical Association. 1991;198(11):1945-1947.

[19] Perkins JD, Timoney JF, Fogle CA, Schumacher J. Guttural pouch empyema and chondroids in horses: a review of 30 cases. Equine Veterinary Journal. 2004;36(6):512-517.

[20] Dixon PM, McGorum BC, Railton DI, Hawe C, Tremaine WH, Dacre K, et al. Laryngeal paralysis: a study of 375 cases in a mixed-breed population of horses. Equine Veterinary Journal. 2001;33(5):452-458.

[21] Lindahl S, Båverud V, Egenvall A, Aspan A, Gunnarsson A. Comparison of sampling sites and detection methods for Streptococcus equi subsp. equi in horses. Veterinary Record. 2013;172(17):448.

[22] Newton JR, Verheyen K, Wood JL, Chanter N. A comparison of culture and PCR for the detection of Streptococcus equi in clinical samples. Veterinary Record. 2000;147(19):539-542.

[23] Judy CE, Chaffin MK, Cohen ND. Transendoscopic guttural pouch lavage for treatment of guttural pouch empyema in horses. Journal of the American Veterinary Medical Association. 1999;215(11):1664-1667.

[24] Båverud V, Johansson SK, A